Santa Rosa, CA, United States of America

Lori Garcia

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 15(Granted Patents)


Company Filing History:


Years Active: 2016-2022

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Lori Garcia: Innovator in Neuromodulation Technology

Introduction

Lori Garcia is a prominent inventor based in Santa Rosa, CA (US). She has made significant contributions to the field of neuromodulation, holding a total of 3 patents. Her work focuses on developing methods and devices that enhance the efficacy of neuromodulation therapies.

Latest Patents

Lori's latest patents include innovative approaches for monitoring neuromodulation efficacy using biomarkers. One of her patents outlines methods, devices, compositions, and kits designed to assess neuromodulation efficacy based on changes in the level or activity of target biomarkers. This involves comparing baseline and post-modulation levels of biomarkers collected from human subjects. The post-neuromodulation levels can be gathered within a timeframe of about 5 minutes to 14 days after the procedure.

Another patent emphasizes the development of devices and associated methods for monitoring neuromodulation using biomarkers. These advancements are crucial for improving patient outcomes in neuromodulation therapies.

Career Highlights

Throughout her career, Lori has worked with notable companies, including Medtronic Ardian Luxembourg S.a.r.l. and Medtronic Adrian Luxembourg S.a.r.l. Her experience in these organizations has allowed her to refine her expertise in neuromodulation technologies.

Collaborations

Lori has collaborated with talented individuals such as Ayala Hezi-Yamit and Rudy Beasley. These partnerships have contributed to her innovative work in the field.

Conclusion

Lori Garcia is a trailblazer in the realm of neuromodulation, with a focus on utilizing biomarkers to enhance therapy efficacy. Her patents and career achievements reflect her dedication to advancing medical technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…